Related by context. All words. (Click for frequent words.) 69 malignant ascites 69 Pemetrexed 68 docetaxel Taxotere ® 68 Adjuvant chemotherapy 68 recurrent metastatic 68 Surgical resection 68 hypervascular tumors 67 metastatic bladder 67 Mitomycin C 67 MAGE A3 ASCI 67 cisplatin chemotherapy 67 radiolabeled TM# 67 ADVEXIN therapy 67 recurrent refractory 67 ZOLINZA 67 somatostatin analogues 67 Golimumab 67 GnRH agonists 67 recurrent glioblastoma multiforme 66 Gliadel Wafer 66 interferon ribavirin 66 oral deforolimus 66 prostate cancer CRPC 66 Hepatocellular Carcinoma HCC 66 colorectal cancer liver metastases 66 hepatorenal syndrome 66 carcinoid tumors 66 radioiodine therapy 66 papillary renal cell carcinoma 66 cilengitide 66 palifermin 66 nonsmall cell lung cancer 66 unresectable tumors 66 cytoreduction 66 Proxinium TM 66 diabetic gastroparesis 66 relapsed ovarian cancer 65 bevacizumab Avastin 65 corticosteroid therapy 65 thetreatment 65 sorafenib Nexavar 65 subependymal giant cell 65 parathyroidectomy 65 anti angiogenic agents 65 Xelox 65 opioid analgesia 65 metastatic colorectal 65 humanised monoclonal antibody 65 pain palliation 65 chemoradiotherapy 65 gefitinib Iressa 65 FASLODEX 65 benign prostatic hypertrophy BPH 65 mycosis fungoides 65 Kepivance 65 cytotoxic therapy 65 eflornithine 65 rFVIIa 65 chemoradiation therapy 65 Oral corticosteroids 65 aerosolized KL4 surfactant 65 MGd 65 efalizumab 65 Degarelix 65 Mitoxantrone 64 fulvestrant 64 CellCept mycophenolate mofetil 64 trastuzumab Herceptin ® 64 intradermal injection 64 Lilly Gemzar 64 superficial basal cell carcinoma 64 DepoDur 64 chronic thromboembolic pulmonary 64 antiplatelet medications 64 trabectedin 64 ANCA associated 64 IRX 2 64 INCB# [003] 64 basal cell carcinoma BCC 64 TheraSphere 64 ISTODAX 64 Tectin TM 64 corticosteroid dexamethasone 64 invasive candidiasis 64 Cremophor 64 Aviptadil 64 imatinib Gleevec 64 metastatic bone 64 thalidomide Thalomid 64 CINTREDEKIN BESUDOTOX 64 antithrombotic therapy 64 thrombolytic agents 64 histological subtype 64 Vandetanib 64 TEMODAL 64 thrombolytic agent 64 mycophenolate mofetil 64 Sudhir Agrawal D.Phil 64 gastrointestinal stromal tumor 64 antiangiogenic therapy 64 thoracoscopic lobectomy 64 Hurthle cell 64 Fludara ® 64 cetuximab Erbitux ® 64 TORISEL 64 Genasense ® 64 TroVax ® 64 sorafenib tablets 64 anticancer therapy 64 gastrointestinal stromal tumors GIST 64 Aggrastat ® tirofiban hydrochloride 64 recurrent NSCLC 64 Noxafil 64 metastatic GIST 64 overactive bladder syndrome 64 FXIII 64 hepatocellular carcinoma liver 64 ZACTIMA 64 STELARA ™ 64 kidney urologic 64 zalutumumab 64 anthracyclines taxanes 64 Mepact 64 Radiofrequency ablation 64 busulfan 64 myelofibrosis polycythemia vera 63 IV Busulfex 63 induce remission 63 IL# PE#QQR 63 superficial bladder cancer 63 gastroesophageal junction 63 chronic granulomatous disease 63 heparin induced thrombocytopenia 63 metastatic malignant 63 Xeloda capecitabine 63 alpha interferons 63 sodium stibogluconate 63 myeloproliferative disorders 63 Glioblastoma Multiforme 63 metastatic gastric 63 candidemia 63 intraperitoneal chemotherapy 63 FOLFOX6 63 QuadraSphere 63 haematologic malignancies 63 Li Fraumeni Syndrome 63 peritoneal cancer 63 Vidaza azacitidine 63 IV NSCLC 63 commercialize deforolimus 63 hepatocellular cancer 63 Accelerated Partial Breast Irradiation 63 refractory CLL 63 bevacizumab Avastin ® 63 colorectal lung 63 myelodysplastic myeloproliferative diseases 63 ALA PDT 63 Arranon 63 recurrent malignant glioma 63 DOXIL 63 Allovectin 7 ® 63 basiliximab 63 asymptomatic hyperuricemia 63 INVEGA ® 63 primary hyperparathyroidism 63 chemoembolization 63 transarterial 63 Asclera 63 cetuximab Erbitux 63 antibody MAb 63 metastatic pancreatic 63 pediatric acute lymphoblastic 63 medically inoperable 63 liver resection 63 thromboprophylaxis 63 benign uterine 63 EXJADE 63 prostate adenocarcinoma 63 immunosuppressive therapies 63 Doxil ® 63 YONDELIS 63 Jevtana 63 HeFH 63 IV metastatic melanoma 63 tyrosine kinase inhibitors TKIs 63 Gemzar ® 63 transthyretin amyloidosis 63 ixabepilone 63 luteinizing hormone releasing 63 INTEGRILIN R 63 systemic immunosuppressive drugs 63 Eculizumab 63 adjuvant radiation 63 biliary tract cancer 63 epidural steroid injection 63 Temsirolimus 63 terlipressin 63 Papillary 63 liposomal doxorubicin 63 galiximab 63 taxane chemotherapy 63 skeletal metastases 63 cervical lymph nodes 63 vorinostat 63 pancreatic adenocarcinoma 63 relapsed MM 63 Fluorouracil 63 bleomycin 63 DaTscan 63 psoriasis vulgaris 63 weekly subcutaneous injections 63 Helicobacter pylori eradication 63 gemcitabine carboplatin 63 adalimumab Humira 63 Ceflatonin 63 aflibercept VEGF Trap 63 Velcade bortezomib 63 antifibrinolytic 63 Bevacizumab Avastin 63 surgically resectable 63 GnRH agonist 63 juvenile idiopathic arthritis 62 Dacogen decitabine 62 Temodar ® 62 ELACYT 62 fluvastatin 62 investigational therapies 62 Foradil Aerolizer 62 SANVAR 62 debulking surgery 62 erlotinib Tarceva ® 62 forodesine 62 arterial thrombosis 62 pyridostigmine 62 Myelodysplastic Syndrome 62 cytoreductive surgery 62 immunomodulatory agents 62 alefacept 62 chronic myocardial ischemia 62 TTF Therapy 62 inhaled bronchodilators 62 relapsing remitting MS RRMS 62 Cellegesic 62 colorectal liver metastases 62 haematologic 62 Paraplatin ® 62 hyperphenylalaninemia HPA due 62 Orally administered 62 pelvic irradiation 62 fluoropyrimidine 62 EGFR tyrosine kinase inhibitors 62 malignant pleural mesothelioma 62 Torisel 62 chronic GVHD 62 anti androgen 62 Sanvar R 62 clinically localized prostate 62 relapsed ALL 62 flecainide 62 metastatic neuroendocrine tumors 62 percutaneous drainage 62 oral ridaforolimus 62 alteplase 62 pituitary adenomas 62 eosinophilic pneumonia 62 lichen planus 62 refractory prostate cancer 62 Liver transplantation 62 fallopian tube carcinoma 62 Certolizumab pegol 62 allogeneic HSCT 62 intravesical infusion therapy 62 esophagogastric 62 Peginterferon alfa 2b 62 standard chemotherapy regimen 62 complement inhibitor eculizumab 62 malignant neoplasms 62 aromatase inhibitor therapy 62 Pivotal Clinical Trial 62 antimicrobial prophylaxis 62 dexanabinol 62 NATRECOR ® 62 microtubule inhibitor 62 gemcitabine chemotherapy 62 tuberous sclerosis TS 62 Amplimexon 62 hormone LHRH antagonist 62 NMIBC 62 invasive aspergillosis 62 HuMax EGFr 62 pancreatic insufficiency 62 nonmelanoma skin cancers 62 thymic carcinoma 62 endometrial hyperplasia 62 chronic idiopathic thrombocytopenic purpura 62 Recombinant interferon alpha 62 Perforomist ™ Inhalation Solution 62 CTEPH 62 neoadjuvant setting 62 Kamada AAT 62 opioid induced constipation OIC 62 denileukin diftitox 62 pamidronate 62 Evoltra TM 62 acetonide FA 62 urothelial cancer 62 bladder prostate 62 topical formulations 62 MYCAMINE 62 Dupuytren Contracture 62 nonischemic 62 Stage IIB 62 secondary hyperparathyroidism 62 Squamous 62 trastuzumab Herceptin 62 Etanercept 62 imexon 62 post thrombotic syndrome 62 Sezary syndrome 62 gemcitabine cisplatin 62 Mohs micrographic surgery 62 intravenous bisphosphonates 62 receptor tyrosine kinase inhibitor 62 Seliciclib 62 PegIntron 62 Venous thromboembolism 62 efaproxiral 62 Cloretazine 62 androgen ablation 62 carcinoma HCC 62 histone deacetylase inhibitor 62 gastric adenocarcinoma 62 metastatic malignant melanoma 62 cinacalcet 62 samalizumab 62 mitomycin C 62 pancreatic prostate 62 spinal metastases 62 Octreolin 62 investigational immunotherapy 62 hepatic metastases 62 fibrate drugs 62 erlotinib Tarceva 62 pouchitis 62 xanthine oxidase inhibitor 62 antimetabolite 62 Dacogen injection 62 osteoarthritic pain 62 Pfizer Sutent 62 biologic therapy 62 Gleevec imatinib 62 Novartis Afinitor 62 irinotecan oxaliplatin 62 vascular thrombosis 62 MyVax R 62 portal vein thrombosis 62 vandetanib 62 Squamous Cell Carcinoma 62 G#DT 62 KRAS mutations occur 62 EGFR inhibitors 62 prostate carcinomas 62 Candida infection 62 biphosphonates 62 monoclonal antibody conjugated 62 urothelial carcinoma 62 sunitinib Sutent 62 Glioblastoma Multiforme GBM 62 lung pancreatic 62 RAS mutations 62 KRAS status 62 metastatic lymph nodes 62 Natalizumab 62 precancerous condition 62 fallopian tube cancers 62 Teriparatide 62 trans retinoic acid 62 advanced medullary thyroid 62 prostate carcinoma 62 Enzyme Replacement Therapy 62 Oxaliplatin 62 MALT lymphoma 62 situ CIS 62 ORENCIA R 62 metastatic adenocarcinoma 62 adriamycin 62 Ixempra 62 therapeutic regimens 62 femoral fractures 62 verteporfin 62 pertuzumab 62 hypertrophic scarring 62 leiomyomas 62 chemotherapy induced neutropenia 62 erythema nodosum 62 recombinant tissue plasminogen 62 DCVax Brain 62 thrombolytics 62 deferoxamine 62 leflunomide 62 Methylnaltrexone 62 anticlotting drugs 62 pancreatic neuroendocrine tumors 62 Solid Tumors 62 MyVax ® 62 peritoneal carcinomatosis 62 Sapacitabine 62 EGFRIs 62 hematologic disorders 62 poloxamer 62 neratinib 62 dosage regimens 61 NAVISTAR R 61 assessing T DM1 61 azacitidine 61 abacavir Ziagen 61 Combidex 61 EGFR expressing 61 GIST tumors 61 Irinotecan 61 transplantation HCT 61 Clolar ® 61 NATRECOR R 61 β blockers 61 Ketotransdel TM 61 bortezomib Velcade 61 tumoral 61 liposomal amphotericin B 61 KETEK 61 Hydroxyurea 61 metastatic renal 61 docetaxel Taxotere 61 HER2 expression 61 TNF antagonist 61 Azedra 61 osteoporotic compression fractures 61 CTAP# Capsules 61 Arikace 61 neoadjuvant therapy 61 FOLFOX4 61 antitumor effect 61 immunomodulators 61 lymphoid malignancies 61 budesonide foam 61 either acutely decompensated 61 methylnaltrexone 61 knee osteoarthritis OA 61 cranial radiation 61 radiotherapy RT 61 Metastatic breast cancer 61 DVT prophylaxis 61 Surgical excision 61 bronchogenic carcinoma 61 decompressive surgery 61 ureteral stents 61 levodopa therapy 61 Navelbine ® 61 acute GvHD 61 hypereosinophilic syndrome 61 pharmacologic intervention 61 Myelodysplastic syndromes MDS 61 thrombotic complications 61 docetaxel chemotherapy 61 Lenocta 61 Egrifta 61 TYZEKA 61 torsade de pointes 61 adjuvant radiotherapy 61 Vincristine 61 tissue plasminogen activator tPA 61 SCCHN 61 prehospital setting 61 Embozene TM Microspheres 61 thoracolumbar spine 61 CYT# potent vascular disrupting 61 Acute myeloid leukemia 61 rotigotine transdermal patch 61 5 fluorouracil leucovorin 61 chimeric monoclonal antibody 61 citalopram hydrobromide 61 mRCC 61 meropenem 61 lexidronam injection 61 LOVENOX R 61 pancreatic colon 61 sipuleucel T 61 flutamide 61 treating neuropathic pain 61 extrapleural pneumonectomy 61 griseofulvin 61 TYGACIL 61 ranibizumab Lucentis 61 concurrent chemoradiation 61 RECIST Response Evaluation Criteria 61 CIMZIA R 61 Hormonal therapy 61 basal cell skin 61 intra articular injection 61 antiplatelet medication 61 Tacrolimus 61 uterine fibroid 61 Abatacept 61 weekly intravenous infusions 61 immunomodulatory therapy 61 Kit CD# positive 61 TASKi3 61 catheter occlusion 61 Zolinza 61 breast endometrial 61 prostate bladder 61 primary immunodeficiency PI 61 refractory angina 61 external beam radiotherapy 61 DCVax R 61 BENICAR HCT 61 osteoporotic vertebral compression fractures 61 Aflibercept 61 Tekamlo 61 treating cancerous tumors 61 intra abdominal infections 61 TNF blocker 61 Deferiprone 61 standard chemotherapy regimens 61 tumor necrosis 61 Plaquenil 61 systemic ALCL 61 NeuroStar TMS Therapy 61 metastatic androgen independent 61 hemorrhagic cystitis 61 pre operatively 61 stage IIIB IV 61 Cimzia TM 61 ADPKD 61 posterior uveitis 61 colorectal adenocarcinoma 61 antidiabetic drugs 61 resectable 61 SIR Spheres 61 Glioblastoma multiforme GBM 61 ThermoDox R 61 Azathioprine 61 cediranib 61 octreotide implant 61 Azacitidine 61 perioperatively 61 IgG1 monoclonal antibody 61 Combination therapy 61 Cx# [002] 61 lung resection 61 Evoltra ® 61 EndoTAGTM 1 61 Immunotherapeutic 61 Adjuvant therapy 61 Hormone Refractory Prostate Cancer 61 ELOXATIN 61 drug ISA# 61 Friedreich Ataxia FRDA 61 INTELENCE 61 Chemophase 61 Onrigin 61 biologic DMARD 61 venous stasis ulcers 61 LHRH receptor positive 61 Cancidas 61 precancerous cervical lesions 61 Neoadjuvant chemotherapy 61 postoperative atrial fibrillation 61 SIMPONI TM 61 GAMMAGARD 61 antithrombotic agents 61 recurrent glioblastoma multiforme GBM 61 anthracycline chemotherapy 61 nonmetastatic 61 localized prostate 61 goserelin 61 microsphere therapy 61 Interferon beta 1b 61 ductal adenocarcinoma 61 unresectable stage 61 systemic corticosteroid 61 Abiraterone acetate 61 calcineurin inhibitor 61 mecasermin 61 PREZISTA r 61 MNTX 61 FIRMAGON 61 curative therapy 61 chemoresistant 61 HoFH 61 non hodgkin lymphoma 61 tacrolimus ointment 61 rheumatoid arthritis psoriatic arthritis 61 octreotide LAR 61 neoadjuvant treatment 61 choroidal vasculopathy 61 ATL# [001] 61 rituximab Rituxan 61 SUTENT 61 metastatic hormone refractory 61 dexrazoxane 61 unstable angina UA 61 postoperative infection 61 5-fluorouracil/leucovorin 61 allogeneic bone marrow 61 OvaRex ® MAb 61 vismodegib 61 Taxol paclitaxel 61 precursor lesions 61 benign prostatic hypertrophy 61 Chronic lymphocytic leukemia 61 neurogenic bladder 61 stratifying patients 61 Zarnestra 61 microwave hyperthermia 61 atrial arrhythmias 61 TAXOTERE R 61 T#I [002] 61 hyperplasia BPH 61 Fludara 61 Taxotere docetaxel 61 cidofovir 61 SNT MC# 61 breast pancreatic 61 Parnate 61 omega interferon 61 Hycamtin 61 idraparinux 61 pelvic lymphadenectomy 61 docetaxel Taxotere R 61 enzastaurin 61 Myelodysplastic Syndrome MDS 61 baseline LDH 61 Enzastaurin 61 chronic ITP patients 61 IV melanoma 61 recurrent glioblastoma 61 clot dissolving drug 61 AVASTIN 61 STRIDE PD 61 heterozygous FH 61 Aprotinin 61 alpha1 antitrypsin deficiency 61 taxane therapy 61 gadobutrol 61 INFUSE Bone Graft 61 Tarceva TM 61 lung liver pancreas 61 sargramostim 61 GORE TAG Device 61 glucocorticoid therapy 61 iron chelation therapy 61 FRAGMIN R 61 IV tPA 61 atypical Hemolytic Uremic Syndrome 61 lymph node enlargement 61 Pseudomonas aeruginosa infections 61 mitoxantrone plus 61 pancreatic ovarian 60 thymoma 60 SGLT2 inhibitors 60 Intravenous immunoglobulin 60 p# biomarker 60 aspirin clopidogrel 60 underwent surgical resection 60 Caelyx 60 antibiotic regimens 60 adenomatous 60 Zoledronic acid 60 immunological diseases 60 androgen deprivation 60 Xanafide 60 Dabigatran 60 endoscopic resection 60 cirrhosis liver failure 60 eniluracil 60 Bevacizumab 60 Decitabine 60 endocrine therapies 60 preoperative chemotherapy 60 Critical Limb Ischemia CLI 60 ClearPath HDR 60 targeted antifolate 60 radiofrequency ablation RFA 60 Warfarin Coumadin 60 nitrofurantoin 60 riociguat 60 Severe VOD 60 phase IIb trial 60 leukemia AML 60 aromatase inhibitors AIs 60 PAOD 60 GW# [003] 60 AMEVIVE 60 neurologic progression 60 PSMA ADC 60 pulmonary hypertension PH 60 pimecrolimus 60 Soliris eculizumab 60 cholangiocarcinoma 60 recurrent GBM 60 depsipeptide 60 psoriasis Crohn disease 60 aldosterone antagonist 60 metastatic renal cell carcinoma 60 diabetic retinopathy DR 60 benign prostatic hyperplasia enlarged 60 VAPRISOL 60 TNF Tumor Necrosis Factor 60 Removab 60 Roche Herceptin 60 esophageal candidiasis 60 antihypertensive therapy 60 Prostacyclin 60 mTOR inhibitors 60 peritumoral brain edema 60 Gamunex C 60 artery stenosis 60 Toxicities 60 paricalcitol 60 BANZEL 60 Epidermal Growth Factor Receptor 60 nutlin 3a 60 paclitaxel Taxol R 60 lenalidomide Revlimid R 60 diabetic kidney 60 TACI Ig 60 Erbitux cetuximab 60 ACTEMRA TM 60 vemurafenib 60 acute coronary syndromes ACS 60 Trobalt 60 adrenal suppression 60 AEG# 60 osteolytic bone disease 60 systemic corticosteroids 60 vidofludimus 60 BrachySil TM 60 Pazopanib 60 Bendamustine 60 Gleevec imatinib mesylate 60 immunosuppressant therapy 60 advanced hepatocellular carcinoma 60 postoperative chemotherapy 60 hormone LHRH agonist 60 lapatinib Tykerb 60 BEXXAR Therapeutic Regimen 60 Lenalidomide 60 Gleevec resistant 60 treat chronic sinusitis 60 romiplostim 60 antithymocyte globulin 60 Resten NG 60 DepoCyt 60 pancreatic carcinoma 60 anthracycline taxane 60 etanercept Enbrel 60 pleural mesothelioma 60 fibrotic disease 60 paclitaxel Taxol ® 60 bowel resection 60 vinorelbine tartrate 60 hematopoietic cancers 60 eBx 60 DCVax ® Brain 60 lumbar disk herniation 60 ESBA# 60 hereditary deficiency 60 Cell Lymphoma CTCL 60 stereotactic radiotherapy 60 differentiated thyroid 60 paraspinal muscles 60 Anti Bacterial Envelope 60 thromboembolic disease 60 Lubiprostone 60 recurrent squamous cell carcinoma 60 strontium ranelate 60 ADP receptor antagonist 60 transdermally 60 cutaneous lupus 60 salmeterol fluticasone 60 OPAXIO 60 hemostatic efficacy 60 EGFR blockers 60 malignant pleural effusion 60 CMV infection 60 Severe Primary IGFD 60 dopaminergic therapy 60 radiation therapy SBRT 60 anakinra 60 thiazide diuretic 60 multiple myeloma MM 60 intestinal polyps 60 immunosuppressives 60 EFAPROXYN 60 pegylated interferon alfa 60 nasopharyngeal carcinoma 60 irinotecan chemotherapy 60 hormone refractory metastatic prostate 60 Radioimmunotherapy 60 epoprostenol 60 intradermal injections 60 Campath alemtuzumab 60 Bosentan 60 valacyclovir Valtrex 60 dasatinib Sprycel ® 60 epidural steroid injections 60 intra arterial chemotherapy 60 Safinamide 60 polyarticular 60 Known hypersensitivity 60 pegylated alpha interferon 60 RhuDex ® 60 immune thrombocytopenic purpura ITP 60 osteoid osteoma 60 concomitant medications 60 allogeneic transplantation 60 occlusive disease 60 injected subcutaneously 60 Neupogen ® 60 LHRH agonists 60 ablative therapy 60 neuroendocrine tumors 60 idarubicin 60 HIV HCV coinfected 60 5-FU/LV 60 hypertrophic scars 60 thymectomy 60 NovoTTF #A 60 neovascular diseases 60 VEGF inhibitors 60 adult chronic ITP 60 repigmentation 60 refractory chronic lymphocytic 60 neoadjuvant radiation 60 Tasimelteon 60 Pertuzumab 60 macrolide antibiotic 60 dasatinib Sprycel 60 artery embolization 60 Tavocept 60 induced macular edema 60 Phase IIb clinical trials 60 Gemcitabine 60 BoNTA 60 baminercept 60 5 Fluorouracil 60 Tamibarotene 60 cranial irradiation 60 Advexin 60 ZYTIGA 60 treat brain aneurysms 60 severe renal impairment 60 intravenous tPA 60 IAP inhibitor 60 ZOMETA 60 Basal cell 60 antirheumatic 60 SNT-MC#/idebenone 60 Soft Tissue Sarcoma 60 metastatic HRPC 60 HBV vaccine 60 recurrent glioma 60 intraperitoneal therapy 60 refractory ovarian cancer 60 chemo radiotherapy 60 neuroendocrine carcinoma 60 EGFR mutation positive 60 bone marrow suppression 60 diabetic ulcer 60 Fingolimod 60 MMP inhibitors 60 BRAF V# mutation 60 severe hypersensitivity reactions 60 ocular allergies 60 Virulizin ® 60 lung fibrosis 60 Neuradiab 60 tumor lysis syndrome 60 symptomatic benign prostatic 60 NSAID therapy 60 immune modulatory 60 platelet inhibitor 60 nodal metastasis 60 UPLYSO 60 SHPT 60 parathyroid 60 Corticosteroids 60 malignant pleural mesothelioma MPM 60 chronic periodontitis 60 esophageal gastric 60 Nilotinib 60 Vascular Wrap 60 Certican 60 nimodipine 60 gallium nitrate 60 pegylated interferon ribavirin 60 treprostinil 60 BRCA deficient 60 infliximab Remicade 60 direct thrombin inhibitors 60 Mimpara 60 monoclonal anti 60 FluCAM arm 60 gemcitabine Gemzar 60 leukotriene receptor antagonist 60 APTIVUS ritonavir 60 Bayer Nexavar 60 Alphanate R 60 hormone refractory 60 Cetuximab 60 Solid Tumors criteria 60 intravenous tissue plasminogen 60 antiemetics 60 clevidipine 60 HIPEC 60 polycythemia vera PV 60 temozolomide Temodar 60 interventional therapies 60 operable breast cancer 60 administered systemically 60 epithelial ovarian 60 Sutent sunitinib 60 zoledronate 60 Vorinostat 60 long acting bronchodilator 60 Panzem R NCD 60 benign neoplasms 60 ASC J9 60 peptide antigens 60 vincristine doxorubicin 60 Alteplase 60 gastrointestinal stromal tumors 60 MyVax 60 pediatric malignancies 60 oxypurinol 60 bovine thrombin 60 intravesical 60 TheraCIM h R3 60 Tasigna nilotinib 60 immunocompetent patients 60 immunodeficiency disorders 60 Mucositis 60 unresectable liver cancer 60 levodopa induced 60 Cutaneous T 60 Platinol ® cisplatin 60 ImClone Erbitux 60 severe hypercholesterolemia 60 Eisenmenger syndrome 60 paclitaxel Taxol 60 reperfusion therapy 60 Insegia 60 topical calcineurin inhibitors 60 topically administered 60 ischemic colitis 60 infusional 5-FU/LV 60 Cetuximab Erbitux 60 ximelagatran 60 severe oral mucositis 60 intravitreal triamcinolone 60 AZILECT ® 60 NSCLC tumors 60 alkylating agent 60 UCB Cimzia 60 dual endothelin receptor antagonist 60 photosensitizing agent 60 Imprime PGG 60 BAY #-# 60 surgical debulking 60 radiation chemoradiation 60 potentially hepatotoxic 60 Mestinon 60 uterine tumors 60 DAPT 60 empiric treatment 60 Intravesical 60 locoregional 60 pulmonary artery banding 60 CTAP# 60 essential thrombocythemia 60 saline placebo 60 antiresorptive 60 Hodgkin lymphoma HL 60 pulmonary metastases 60 biologic antibody 59 metastatic lung cancer 59 investigational monoclonal antibody 59 VTE prophylaxis 59 REMINYL ® 59 oral clodronate 59 mCRC patients 59 Nephrogenic Systemic Fibrosis NSF 59 Androgen deprivation therapy 59 mapatumumab 59 mutated K ras 59 sodium thiosulfate STS 59 bevacizumab Avastin Genentech 59 arthropathy 59 argatroban